Black J L, Mylecharane E J
Clin Exp Pharmacol Physiol. 1984 Jan-Feb;11(1):27-35. doi: 10.1111/j.1440-1681.1984.tb00236.x.
The antagonist effects of indoramin were investigated in rabbit perfused ear artery, common carotid artery, and human perfused temporal artery preparations. Indoramin was a potent competitive antagonist of the constrictor effects of noradrenaline (NA) in all three preparations, pA2 values being 7.77 for the ear artery, 8.20 for the common carotid artery and 7.46 for the human temporal artery. The constrictor actions of serotonin (5-hydroxytryptamine, 5-HT) were competitively antagonized by indoramin. The pA2 values obtained in the rabbit common carotid and human temporal artery (5.92 and 6.25, respectively), were lower than those for NA in the same preparations and lower than that obtained in the rabbit perfused ear artery (7.55). Indoramin was a potent competitive antagonist (pA2:8.31) of histamine-induced vasoconstriction in the rabbit perfused ear artery preparation. These results can be explained on the basis of previous findings that the action of 5-HT in the rabbit ear artery is mediated via an alpha-adrenoceptor, and that the rabbit common carotid artery contains true 5-HT receptors. The findings suggest that specific 5-HT receptors may be present in the human temporal artery and that alpha-adrenoceptor antagonism may be the pharmacological property of most relevance to the efficacy of indoramin in migraine prophylaxis.
在兔灌注耳动脉、颈总动脉及人灌注颞动脉标本上研究了吲哚拉明的拮抗作用。在这三种标本中,吲哚拉明都是去甲肾上腺素(NA)收缩作用的强效竞争性拮抗剂,耳动脉的pA2值为7.77,颈总动脉为8.20,人颞动脉为7.46。血清素(5-羟色胺,5-HT)的收缩作用也被吲哚拉明竞争性拮抗。在兔颈总动脉和人颞动脉中获得的pA2值(分别为5.92和6.25)低于相同标本中NA的pA2值,也低于兔灌注耳动脉中的pA2值(7.55)。在兔灌注耳动脉标本中,吲哚拉明是组胺诱导的血管收缩的强效竞争性拮抗剂(pA2:8.31)。这些结果可根据先前的研究结果来解释,即5-HT在兔耳动脉中的作用是通过α-肾上腺素能受体介导的,且兔颈总动脉含有真正的5-HT受体。这些发现表明,人颞动脉中可能存在特异性5-HT受体,且α-肾上腺素能受体拮抗作用可能是与吲哚拉明预防偏头痛疗效最相关的药理学特性。